Figure 1

Description of the study design. CVD cardiovascular disease, HTN hypertension, MetS metabolic syndrome, T2DM type 2 diabetes mellitus, AIP atherogenic index of plasma.

Description of the study design. CVD cardiovascular disease, HTN hypertension, MetS metabolic syndrome, T2DM type 2 diabetes mellitus, AIP atherogenic index of plasma.